Evidence map›Paper›PMID 40766444›Full record

ArticlebioRxiv : the preprint server for biology2025

A combinatorial mutational map of active non-native protein kinases by deep learning guided sequence design.

Kosuke Seki, Amy B Guo, Deniz Akpinaroglu, Tanja Kortemme

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kosuke SekiDepartment of Bioengineering and Therapeutic Sciences, University of California, San Francisco; San Francisco, CA 94143, USA.ORCID 0000-0002-0413-8184
Amy B GuoDepartment of Bioengineering and Therapeutic Sciences, University of California, San Francisco; San Francisco, CA 94143, USA.ORCID 0000-0003-4775-9498
Deniz AkpinarogluDepartment of Bioengineering and Therapeutic Sciences, University of California, San Francisco; San Francisco, CA 94143, USA.ORCID 0000-0002-5482-0720
Tanja KortemmeDepartment of Bioengineering and Therapeutic Sciences, University of California, San Francisco; San Francisco, CA 94143, USA.ORCID 0000-0002-8494-680X

Funding

Equipment Supplement - Computational design of proteins and protein functionsR35GM145236 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KORTEMME, TANJA · 2022 to 2025
$2.4M
Illumina NovaSeq 6000 Sequencing SystemS10OD028511 · OD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CHOW, ERIC D · 2020 to 2020
$583k
NIGMS NIH HHS R35 GM145236NIH HHS S10 OD028511
6 · The paper itself

Abstract

Mapping protein sequence-function landscapes has either been limited to small steps (only few mutations) or to sequences similar to those already explored by evolution to maintain activity. Here, we overcome both limitations by applying deep-learning guided redesign to a natural protein tyrosine kinase to generate novel, functional sequences with highly combinatorial mutations. Using cell-free assays, we measure the activities and concentrations of 537 redesigned sequences, which differ from the wild-type by an average of 37 mutations while retaining activity in 85% of variants. These sequences sample 436 unique mutations at 76 different positions throughout the kinase domain. A simple regression model identifies key sequence determinants of function and predicts the function of unseen sequences. Our approach demonstrates how integrating deep-learning guided redesign, functional measurement at scale, and interpretable computational modelling enables functional exploration of highly combinatorial and sparse sequence-function landscapes at mutational scales not possible before.

Identifiers

PMID40766444
PMCPMC12324526

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.